OBJECTIVES/HYPOTHESIS: Salvage laryngectomy after failed organ preservation often has a high complication rate, pharyngocutaneous fistulas being the most common. These fistulas increase morbidity, prolong hospitalization, and potentially delay adjuvant treatment. Fistula rates in the literature range from 3% to 65%. Use of the pectoralis flap to prevent fistula formation has been adopted as a common practice at our institution. A review of our experience using the overlay myofascial showed a higher than desired complication rate. The aim of this study is to assess whether the use of integrated myocutaneous flap results in a lower fistula rate. STUDY DESIGN: A retrospective review of 30 patients followed by a pilot study of 10 patients. All underwent salvage laryngectomy after failed organ preservation. METHODS: The operation notes of 40 laryngectomy patients were analyzed. The patient/tumor characteristics, pretreatment, neck dissection, flap type, and fistula rate were documented. RESULTS: The patient sample was 25% female. All patients received prior radiotherapy, but only 37.5% received prior chemoradiation. Neck dissections were performed in 80% of these patients, 76% of the myocutaneous group, and 84% of the myofascial group. Advanced tumor stage was found in 42% of the myofascial group and 52% of the myocutaneous group. Five of the 19 myofascial patients developed a fistula, whereas seven of the 21 myocutaneous patients developed a fistula. CONCLUSIONS: The use of the pectoralis myocutaneous flap (PMCF) in this pilot series did not show a lower rate of fistula; other alternatives should be pursued to decrease this complication. LEVEL OF EVIDENCE: 4.
OBJECTIVES/HYPOTHESIS: Salvage laryngectomy after failed organ preservation often has a high complication rate, pharyngocutaneous fistulas being the most common. These fistulas increase morbidity, prolong hospitalization, and potentially delay adjuvant treatment. Fistula rates in the literature range from 3% to 65%. Use of the pectoralis flap to prevent fistula formation has been adopted as a common practice at our institution. A review of our experience using the overlay myofascial showed a higher than desired complication rate. The aim of this study is to assess whether the use of integrated myocutaneous flap results in a lower fistula rate. STUDY DESIGN: A retrospective review of 30 patients followed by a pilot study of 10 patients. All underwent salvage laryngectomy after failed organ preservation. METHODS: The operation notes of 40 laryngectomy patients were analyzed. The patient/tumor characteristics, pretreatment, neck dissection, flap type, and fistula rate were documented. RESULTS: The patient sample was 25% female. All patients received prior radiotherapy, but only 37.5% received prior chemoradiation. Neck dissections were performed in 80% of these patients, 76% of the myocutaneous group, and 84% of the myofascial group. Advanced tumor stage was found in 42% of the myofascial group and 52% of the myocutaneous group. Five of the 19 myofascialpatients developed a fistula, whereas seven of the 21 myocutaneous patients developed a fistula. CONCLUSIONS: The use of the pectoralis myocutaneous flap (PMCF) in this pilot series did not show a lower rate of fistula; other alternatives should be pursued to decrease this complication. LEVEL OF EVIDENCE: 4.
Authors: Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2014-04-23 Impact factor: 2.503
Authors: Armando De Virgilio; Andrea Costantino; Giuseppe Mercante; Fabio Ferreli; Bianca Maria Festa; Elena Russo; Luca Malvezzi; Raul Pellini; Giovanni Colombo; Giuseppe Spriano Journal: Eur Arch Otorhinolaryngol Date: 2022-06-22 Impact factor: 2.503
Authors: Asif Ali Arain; Muhammad Shaheryar Ahmed Rajput; Shabbir Akhtar; Arsalan A Rajput; Mohammad Adeel; Ahmad Hatem; Ahmed Nadeem Abbasi Journal: Cureus Date: 2020-04-06
Authors: Linke Li; Jing Wang; Di Deng; Tian Shen; Weigang Gan; Feng Xu; Jifeng Liu; Dan Lv; Bo Li; Ji Wang; Jun Wang; Fei Chen; Jun Liu Journal: Medicine (Baltimore) Date: 2021-01-15 Impact factor: 1.817